Legal Representation
Attorney
Jared M. Barrett
USPTO Deadlines
Application History
45 events| Date | Code | Type | Description | Documents |
|---|---|---|---|---|
| Aug 19, 2024 | MAB6 | E | ABANDONMENT NOTICE E-MAILED - NO USE STATEMENT FILED | Loading... |
| Aug 19, 2024 | ABN6 | S | ABANDONMENT - NO USE STATEMENT FILED | Loading... |
| Jan 20, 2024 | EXRA | E | NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED | Loading... |
| Jan 18, 2024 | EX4G | S | SOU EXTENSION 4 GRANTED | Loading... |
| Jan 18, 2024 | EXT4 | S | SOU EXTENSION 4 FILED | Loading... |
| Jan 18, 2024 | EEXT | I | SOU TEAS EXTENSION RECEIVED | Loading... |
| Jul 19, 2023 | EXRA | E | NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED | Loading... |
| Jul 17, 2023 | EX3G | S | SOU EXTENSION 3 GRANTED | Loading... |
| Jul 17, 2023 | EXT3 | S | SOU EXTENSION 3 FILED | Loading... |
| Jul 17, 2023 | EEXT | I | SOU TEAS EXTENSION RECEIVED | Loading... |
| Jan 19, 2023 | EXRA | E | NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED | Loading... |
| Jan 17, 2023 | EX2G | S | SOU EXTENSION 2 GRANTED | Loading... |
| Jan 17, 2023 | EXT2 | S | SOU EXTENSION 2 FILED | Loading... |
| Jan 17, 2023 | EEXT | I | SOU TEAS EXTENSION RECEIVED | Loading... |
| Jul 20, 2022 | EXRA | E | NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED | Loading... |
| Jul 18, 2022 | EX1G | S | SOU EXTENSION 1 GRANTED | Loading... |
| Jul 18, 2022 | EXT1 | S | SOU EXTENSION 1 FILED | Loading... |
| Jul 18, 2022 | EEXT | I | SOU TEAS EXTENSION RECEIVED | Loading... |
| Mar 23, 2022 | CHAN | I | APPLICANT/CORRESPONDENCE CHANGES (NON-RESPONSIVE) ENTERED | Loading... |
| Mar 23, 2022 | TCCA | I | TEAS CHANGE OF CORRESPONDENCE RECEIVED | Loading... |
| Mar 23, 2022 | COAR | I | TEAS CHANGE OF OWNER ADDRESS RECEIVED | Loading... |
| Jan 18, 2022 | NOAM | E | NOA E-MAILED - SOU REQUIRED FROM APPLICANT | Loading... |
| Nov 23, 2021 | NPUB | E | OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED | Loading... |
| Nov 23, 2021 | PUBO | A | PUBLISHED FOR OPPOSITION | Loading... |
| Nov 3, 2021 | NONP | E | NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED | Loading... |
| Oct 20, 2021 | CNSA | P | APPROVED FOR PUB - PRINCIPAL REGISTER | Loading... |
| Oct 20, 2021 | XAEC | I | EXAMINER'S AMENDMENT ENTERED | Loading... |
| Oct 20, 2021 | GNEN | O | NOTIFICATION OF EXAMINERS AMENDMENT E-MAILED | Loading... |
| Oct 20, 2021 | GNEA | O | EXAMINERS AMENDMENT E-MAILED | Loading... |
| Oct 20, 2021 | CNEA | R | EXAMINERS AMENDMENT -WRITTEN | Loading... |
| Oct 20, 2021 | GPRN | O | NOTIFICATION OF PRIORITY ACTION E-MAILED | Loading... |
| Oct 20, 2021 | GPRA | O | PRIORITY ACTION E-MAILED | Loading... |
| Oct 20, 2021 | CPRA | R | PRIORITY ACTION WRITTEN | Loading... |
| Oct 20, 2021 | ZZZX | Z | PREVIOUS ALLOWANCE COUNT WITHDRAWN | Loading... |
| Oct 12, 2021 | PBCR | Z | WITHDRAWN FROM PUB - OG REVIEW QUERY | Loading... |
| Sep 27, 2021 | CNSA | P | APPROVED FOR PUB - PRINCIPAL REGISTER | Loading... |
| Sep 27, 2021 | XAEC | I | EXAMINER'S AMENDMENT ENTERED | Loading... |
| Sep 27, 2021 | GNEN | O | NOTIFICATION OF EXAMINERS AMENDMENT E-MAILED | Loading... |
| Sep 27, 2021 | GNEA | F | EXAMINERS AMENDMENT E-MAILED | Loading... |
| Sep 27, 2021 | CNEA | R | EXAMINERS AMENDMENT -WRITTEN | Loading... |
| Sep 24, 2021 | DOCK | D | ASSIGNED TO EXAMINER | Loading... |
| Sep 22, 2021 | ASGN | I | AUTOMATIC UPDATE OF ASSIGNMENT OF OWNERSHIP | Loading... |
| Jul 9, 2021 | MDSM | E | NOTICE OF DESIGN SEARCH CODE E-MAILED | Loading... |
| Jul 8, 2021 | NWOS | I | NEW APPLICATION OFFICE SUPPLIED DATA ENTERED | Loading... |
| Apr 2, 2021 | NWAP | I | NEW APPLICATION ENTERED | Loading... |
Detailed Classifications
Class 005
Pharmaceutical preparations and therapeutic agents for reprogramming the immune system; pharmaceutical and therapeutic agents for use as immunotherapies; pharmaceutical preparations and therapeutic agents for selectively suppressing immune cells; pharmaceutical preparations and therapeutic agents for inducing immune tolerance
Class 042
Medical and clinical research and development for others in the field of immunology; medical and clinical research and development for others in the field of immunotherapies; medical and clinical research and development for others in the field of nucleic acid-based technology for selectively suppressing immune cells; medical and clinical research and development for others in the field of nucleic acid-based technology for inducing immune tolerance; consulting services in the field of immunotherapy research, transplanted tissues and organs research, and drug discovery and development; medical laboratory research; scientific research; medical laboratory services
Class 044
Health care services, namely, medical analysis services for diagnostic, treatment and information purposes provided by medical laboratories; health assessment services; health monitoring services, namely, monitoring immune status of individuals for diagnostic, treatment and information purposes; advisory services relating to health; providing information in the field of health
Additional Information
Design Mark
The mark consists of an array of seven shaded-in circles arranged in a general square outline with three shaded-in tear drop elements with a shaded-in circle at each end appearing within the square and wherein the tear drop elements are connected together to form linked structures, to the right is the word, "ADITXT", appearing above the smaller wording, "IMMUNE HEALTH".
Pseudo Mark
ADITX THERAPEUTICS IMMUNE HEALTH
Classification
International Classes
005
042
044
Disclaimers
The following terms have been disclaimed and are not claimed as part of the trademark:
Specific Disclaimer
"IMMUNE HEALTH"